Janus Henderson Investors US’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Janus Henderson Investors US’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$85.5M	Sell	5,361,171 -826,417	-13%	-$11.9M	0.07%	319
2016 Q4	$78M	Sell	6,187,588 -122,489	-2%	-$2.28M	0.07%	350
2016 Q3	$177M	Buy	6,310,077 +108,676	+2%	+$3.65M	0.15%	191
2016 Q2	$217M	Sell	6,201,401 -261,116	-4%	-$8.21M	0.18%	154
2016 Q1	$177M	Buy	6,462,517 +520,334	+9%	+$15.3M	0.15%	182
2015 Q4	$203M	Buy	5,942,183 +2,179,660	+58%	+$68M	0.17%	154
2015 Q3	$108M	Buy	3,762,523 +224,822	+6%	+$9.61M	0.1%	263
2015 Q2	$158M	Buy	+3,537,701	New	+$133M	0.13%	219

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Janus Henderson Investors US's DPLO Position: Q1 2017 in Review

Janus Henderson Investors US reduced its DIPLOMAT PHARMACY, INC. (DPLO) stake by 13% in Q1 2017, selling an estimated $11.9M and leaving 5,361,171 shares worth $85.5M. The position accounts for 0.07% of the portfolio, ranked #319.

Janus Henderson Investors US first reported a position in DPLO in Q2 2015 and has held it in 8 quarters since. The position peaked at $217M in Q2 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

Janus Henderson Investors US held 5,361,171 shares of DIPLOMAT PHARMACY, INC. worth $85.5M as of Q1 2017.
Janus Henderson Investors US sold 826,417 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $11.9M.
DIPLOMAT PHARMACY, INC. made up 0.07% of Janus Henderson Investors US's portfolio in Q1 2017, its #319 holding.
Janus Henderson Investors US first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and has held it in 8 quarters since.
Janus Henderson Investors US's DIPLOMAT PHARMACY, INC. position peaked at $217M in Q2 2016.
155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.